Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toyohiko Yokoi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Blood Pressure Monitoring|May 2, 2015
Validation of two automatic devices: Omron HEM-7252G-HP and Omron HEM-7251G for self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010Hakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Vascular Health and Risk Management|June 8, 2013
Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010Hakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Blood Pressure Monitoring|December 3, 2014
Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500FHakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Blood Pressure Monitoring|June 25, 2011
Validation of home blood pressure-monitoring devices, Omron HEM-1020 and Omron i-Q132 (HEM-1010-E), according to the European Society of Hypertension International ProtocolHakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Vascular Health and Risk Management|February 7, 2015
Validation of two automatic devices for the self-measurement of blood pressure according to the ANSI/AAMI/ISO81060-2:2009 guidelines: the Omron BP765 (HEM-7311-ZSA) and the Omron BP760N (HEM-7320-Z)Hakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Clinical Calcium|October 4, 2005
[Calcium antagonists and endothelial function]Osamu Yasuda, Hidenobu Kawamoto, Toyohiko Yokoi, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 30, 2010
Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonistsMasamichi Yoshika, Yutaka Komiyama, Midori Masuda, et al.
BMC Public Health|January 22, 2021
Effects of social network incentives and financial incentives on physical activity and social capital among older women: a randomized controlled trialRyo Yamashita, Shinji Sato, Ryoichi Akase, et al.
Diabetes|May 30, 2006
Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cellsToyohiko Yokoi, Keisuke Fukuo, Osamu Yasuda, et al.
Hypertension (Dallas, Tex. : 1979)|February 18, 2004
Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expressionYukihiro Takemura, Keisuke Fukuo, Osamu Yasuda, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Blood Pressure Monitoring|May 2, 2015
Validation of two automatic devices: Omron HEM-7252G-HP and Omron HEM-7251G for self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010Hakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Vascular Health and Risk Management|June 8, 2013
Validation of Omron RS8, RS6, and RS3 home blood pressure monitoring devices, in accordance with the European Society of Hypertension International Protocol revision 2010Hakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Blood Pressure Monitoring|December 3, 2014
Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: the Omron HEM-7130, HEM-7320F, and HEM-7500FHakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Blood Pressure Monitoring|June 25, 2011
Validation of home blood pressure-monitoring devices, Omron HEM-1020 and Omron i-Q132 (HEM-1010-E), according to the European Society of Hypertension International ProtocolHakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Vascular Health and Risk Management|February 7, 2015
Validation of two automatic devices for the self-measurement of blood pressure according to the ANSI/AAMI/ISO81060-2:2009 guidelines: the Omron BP765 (HEM-7311-ZSA) and the Omron BP760N (HEM-7320-Z)Hakuo Takahashi, Masamichi Yoshika, Toyohiko Yokoi
Clinical Calcium|October 4, 2005
[Calcium antagonists and endothelial function]Osamu Yasuda, Hidenobu Kawamoto, Toyohiko Yokoi, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 30, 2010
Pitavastatin further decreases serum high-sensitive C-reactive protein levels in hypertensive patients with hypercholesterolemia treated with angiotensin II, type-1 receptor antagonistsMasamichi Yoshika, Yutaka Komiyama, Midori Masuda, et al.
BMC Public Health|January 22, 2021
Effects of social network incentives and financial incentives on physical activity and social capital among older women: a randomized controlled trialRyo Yamashita, Shinji Sato, Ryoichi Akase, et al.
Diabetes|May 30, 2006
Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cellsToyohiko Yokoi, Keisuke Fukuo, Osamu Yasuda, et al.
Hypertension (Dallas, Tex. : 1979)|February 18, 2004
Fas signaling induces Akt activation and upregulation of endothelial nitric oxide synthase expressionYukihiro Takemura, Keisuke Fukuo, Osamu Yasuda, et al.
Pageof 2